Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs. - Wikidata - awgldk - TriplyDB

Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs.

Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs.

http://www.wikidata.org/entity/Q39834038

about

In vitro and in vivo antibacterial activity of AM-833, a new quinolone derivative Comparative in vitro activity of WIN 57273, a new fluoroquinolone antimicrobial agent In vitro and in vivo antibacterial activities of BMY 40062, a new fluoronaphthyridone Evaluation of quinolones in experimental animal models of infections.In vitro activities of fleroxacin against clinical isolates of Legionella spp., its pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia Comparative activities of piperacillin and tazobactam against clinical isolates of Legionella spp.Preparation and evaluation of ofloxacin-loaded palmitic acid solid lipid nanoparticles.Legionnaires disease: historical perspective Laboratory diagnosis of infections caused by legionellae.Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application.Quinolones in the treatment of lower respiratory tract infections caused by intracellular pathogens.Activity of trovafloxacin (CP-99,219) against Legionella isolates: in vitro activity, intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea pigs with L. pneumophila pneumonia Comparative postantibacterial activities of pefloxacin, ciprofloxacin, and ofloxacin against intracellular multiplication of Legionella pneumophila serogroup 1 In vitro activity of sparfloxacin (CI-978; AT-4140) for clinical Legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia.WIN 57273 is bactericidal for Legionella pneumophila grown in alveolar macrophages Comparative evaluation of enoxacin, ofloxacin, ampicillin, and chloramphenicol for treatment of experimental Haemophilus influenzae pneumonia.Effect of quinolones and other antimicrobial agents on cell-associated Legionella pneumophila Inhibition of Legionella pneumophila multiplication within human macrophages by antimicrobial agents.In vitro and in vivo antibacterial activities of T-3761, a new quinolone derivative.In vitro activities of BAY Y3118, ciprofloxacin, ofloxacin, and fleroxacin against gram-positive and gram-negative pathogens from respiratory tract and soft tissue infections.Comparison of charcoal- and starch-based media for testing susceptibilities of Legionella species to macrolides, azalides, and fluoroquinolones.Activity of temafloxacin against respiratory pathogens.Legionellosis in Transplantation.Simplified quantitative assay system for measuring activities of drugs against intracellular Legionella pneumophila.Susceptibilities of Legionella spp. to newer antimicrobials in vitro.Subinhibitory concentrations of antimicrobial agents reduce the uptake of Legionella pneumophila into Acanthamoeba castellanii and U937 cells by altering the expression of virulence-associated antigens.Mode of action, and in vitro and in vivo activities of the fluoroquinolones.Intracellular activity of tosufloxacin (T-3262) against Salmonella enteritidis and ability to penetrate into tissue culture cells of human origin.Fluorometric measurement of ofloxacin uptake by human polymorphonuclear leukocytes.Inhibition of theophylline clearance by coadministered ofloxacin without alteration of theophylline effects.Comparative in vitro activity of CGP 31608, a new penem antibiotic High-performance liquid chromatography measurement of antimicrobial concentrations in polymorphonuclear leukocytes.Efficacy of NY-198 against experimental Legionnaires disease.Comparative evaluation of ciprofloxacin, enoxacin, and ofloxacin in experimental Pseudomonas aeruginosa pneumonia.Accumulation of a newly developed fluoroquinolone, OPC-17116, by human polymorphonuclear leukocytes.Rifampin resistance of Legionella pneumophila is not increased during therapy for experimental Legionnaires disease: study of rifampin resistance using a guinea pig model of Legionnaires disease.Evaluation of a human monocytic cell line THP-1 model for assay of the intracellular activities of antimicrobial agents against Legionella pneumophila.The association of antibiotic treatment regimen and hospital mortality in patients hospitalized with Legionella pneumonia.Multiresistant waterborne pathogens isolated from water reservoirs and cooling systems.Antimicrobial activity of ten macrolide, lincosamine and streptogramin drugs tested against Legionella species.

P2860

Q24685742-C4BE66FA-5F4F-43C5-BF9C-0C56FF65D779 Q28335923-574B1D7A-7657-482D-9B8C-9B6F4259CF7E Q28359405-6FAC52A1-EF63-4D40-8D82-11D8EF1DE82C Q30446615-6B3DACC0-0642-4000-A338-1A6275F5C25C Q33744843-D6C1C59A-57F9-4F35-B29B-0B4F17EFD076 Q33747823-063AF03B-0893-4691-97BD-E8B072AFE492 Q33863671-56E735C5-CD4D-40D4-972F-9A47D98A2D7C Q34164604-5A064830-3B6F-4B5A-948D-F3286AD514DD Q34183542-CB85E42E-D55D-427C-B5A5-2192D43B1EF7 Q34687048-E1070B9C-2BF5-46C8-B9FA-2CBD96E08A32 Q34719806-DF456A5B-58DF-4BC8-906E-2D03195EEBCD Q35122254-42922DA2-B77A-4316-AD2E-CA13ACB95A35 Q35272717-F5BCF939-ECBB-4D00-87EC-691F37CF8507 Q35280841-FB4A42A7-F1BA-4E7B-B697-5211CAA63C68 Q35364046-57746547-1C0B-4520-95BA-A1B501043A44 Q35537723-54874415-2EA7-4E6D-844F-F2068FB96A08 Q35542379-7001D6FE-3F3A-48D5-9572-5631D32BE84F Q35575694-8BE287E3-B945-4BC4-9956-00B43FD48BAA Q35809707-ED6E1295-463A-48AB-BA2C-977594BD49F6 Q35819848-7DC0B725-11DE-40CB-924A-C294931B8299 Q36547774-4638CA68-16E9-425F-82BD-84E21F25C39A Q36753020-2EF18B21-8DBD-4D07-AB6D-BED434C90EB8 Q38726663-0E87E257-5F48-4288-844B-567D8C80BC28 Q39553788-05E0A2BD-F7C9-4935-BD2A-408832152EBB Q39557831-9A8A7F0B-708A-4644-966B-AA5AF28E5387 Q39559397-0A533872-5ACF-41B8-9140-1731B08C9959 Q39637667-B16BFC51-0820-43FC-9892-052BC0A94F88 Q39816058-30C63D47-B17B-4515-95F9-C018F1FE39C9 Q39819180-4BB2F8FF-01F0-480B-A260-7682A78C58CF Q39827802-C7C9DD1A-0767-4E66-B2C0-38C64FBD3953 Q39828520-1C3BEFF8-C90F-4BB5-BAB6-EE2626E06BE0 Q39832110-77D9BC00-ACBA-42AB-A3A4-8F9364702CD7 Q39832353-5A45DA26-6B19-4315-96BB-C690B00372DF Q39850865-47FE676F-F030-4D86-A3CE-EF7F14C71DC2 Q39866608-53FE01FB-7870-4666-904B-01059A302C0E Q40085510-218E9336-7FA3-4AE3-968C-20494E53C6C0 Q40851098-BC879646-443C-47C7-8A14-52F1BFB95FC6 Q41461523-E64BA4EC-365D-4598-B375-DFA327AD9405 Q47890331-3F2FB7DB-2C59-4C7A-AE06-A1D1C15558EF Q54265235-A98A01CF-2C21-48EC-BA09-53DF2260FE46

P2860

Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs.

http://www.wikidata.org/entity/Q39834038

description

1985 nî lūn-bûn

@nan

1985年の論文

@ja

1985年学术文章

@wuu

1985年学术文章

@zh-cn

1985年学术文章

@zh-hans

1985年学术文章

@zh-my

1985年学术文章

@zh-sg

1985年學術文章

@yue

1985年學術文章

@zh

1985年學術文章

@zh-hant

name

Susceptibility of Legionella p ...... ella pneumonia in guinea pigs.

@en

Susceptibility of Legionella p ...... ella pneumonia in guinea pigs.

@nl

type

label

Susceptibility of Legionella p ...... ella pneumonia in guinea pigs.

@en

Susceptibility of Legionella p ...... ella pneumonia in guinea pigs.

@nl

prefLabel

Susceptibility of Legionella p ...... ella pneumonia in guinea pigs.

@en

Susceptibility of Legionella p ...... ella pneumonia in guinea pigs.

@nl

P1433

Q39834038-0F82FF5A-B6C5-42F3-8CBE-8EA1622F37CE

P1476

Q39834038-2FD2EBFE-4D8C-41A0-8BC5-3E46BE94D57B

P2093

Q39834038-00064010-04E2-41FF-B1D8-FA83ACAD60C4

Q39834038-47D3D1F9-78C3-478E-BDD0-986F06279B7C

Q39834038-6EC5A921-F873-40E0-83EF-9D935BC84154

Q39834038-71B7AE3A-8A51-4F3A-8A9B-CF6F51270841

Q39834038-7BED1C6E-BEBC-46FB-BC42-5C7CB5CE36F0

Q39834038-7DFF8D2C-AA58-4EBF-BD82-DBB522F7B6F0

Q39834038-84467613-8BFE-4DC4-8748-2E011AC4BAEB

Q39834038-B79E1C47-1BD2-42A6-A046-0002378E5A9C

Q39834038-C31017AC-B30D-415C-8538-3D0AD79B4F9B

Q39834038-DE8E5E36-E4DE-4A06-B07A-EE24614467A6

P2860

Q39834038-05AF2574-822E-4B6A-9AFA-8B8567B8E586

Q39834038-2243CAC3-C5D4-4BBD-BB9D-8D1409A775D8

Q39834038-2C925BB5-52ED-4631-80A4-7487D11FAA77

Q39834038-3E4D4782-4C89-499A-9C4F-7BA0CC91826D

Q39834038-577019A4-873B-4648-9BE0-1E80277B524F

Q39834038-8CE6D6CB-B206-43C7-B6AC-A869AF9D6762

Q39834038-958DB5A9-AF46-47AE-B53A-918C3CB432F5

Q39834038-98913AC7-C764-4ABE-8A6C-B1C91590F6D5

Q39834038-A1F57137-5629-4AE9-8101-D5BD64CFCB1E

Q39834038-A889203C-EFAD-4C38-A72E-64A8A75E53EA

P304

Q39834038-1F10555C-073F-4C04-9763-E02125539522

P31

Q39834038-248C5CA2-D2DA-4308-A5FD-99364ADEC94F

P356

Q39834038-34D8953C-46C4-4CBA-92C5-203A2B1437FD

P407

Q39834038-074C9F89-6FFD-4CBB-8FFB-3E779CC6E0DE

P433

Q39834038-903D16EB-89B3-4239-B020-2DAAC26C335F

P478

Q39834038-C4E59E3E-FE43-4AB4-A3B4-D3089C11EF7B

P577

Q39834038-31BB5641-DB03-4ACF-8A70-A97B4F7AB549

P5875

Q39834038-59AE37F8-A7AE-4004-947B-60928BC8B3AD

P698

Q39834038-CD67DD57-83C3-4889-9153-9B326BBAD9A7

P921

Q39834038-3F62F5D1-6D49-422E-A2F1-7F96D0CCF9CE

P932

Q39834038-F386DCDE-04EB-4E33-B2BF-ABD5A382DB08

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Susceptibility of Legionella p ...... ella pneumonia in guinea pigs.

@en

P2093

Fujita K

http://www.w3.org/2001/XMLSchema#string

Fukuda Y

http://www.w3.org/2001/XMLSchema#string

Koga H

http://www.w3.org/2001/XMLSchema#string

Nagasawa M

http://www.w3.org/2001/XMLSchema#string

Nakazato H

http://www.w3.org/2001/XMLSchema#string

Saito A

http://www.w3.org/2001/XMLSchema#string

Sawatari K

http://www.w3.org/2001/XMLSchema#string

Shigeno Y

http://www.w3.org/2001/XMLSchema#string

Suzuyama Y

http://www.w3.org/2001/XMLSchema#string

Tomonaga A

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g

Susceptibility of Legionella pneumophila to twenty antimicrobial agents.

Intracellular multiplication of Legionnaires' disease bacteria (Legionella pneumophila) in human monocytes is reversibly inhibited by erythromycin and rifampin

Antimicrobial susceptibility of intracellular Legionella pneumophila.

Susceptibility of Pittsburgh pneumonia agent (Legionella micdadei) and other newly recognized members of the genus Legionella to nineteen antimicrobial agents.

Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes.

Antibiotic treatment of guinea-pigs infected with agent of Legionnaires' disease.

Pathogenesis of Pseudomonas aeruginosa pneumonia during immunosuppression.

Legionnaires' disease: report of sixty-five nosocomially acquired cases of review of the literature.

In vivo susceptibility of the Legionnaires disease bacterium to ten antimicrobial agents.

P304

15-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.28.1.15

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

1985-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

19300300

http://www.w3.org/2001/XMLSchema#string

P698

3862361

http://www.w3.org/2001/XMLSchema#string

P921

P932

176301

http://www.w3.org/2001/XMLSchema#string